Showing results (41-50 of 85) with videos related to
Sort By:
Pageof 9
Breast Cancer Research and Treatment|July 10, 2010
Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer familiesPeter Kang, Shivaani Mariapun, Sze Yee Phuah, et al.The International Journal of Biological Markers|May 1, 2009
Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapyRaquel A Nunes, Xiaochun Li, Soonmo Peter Kang, et al.Neuroimage. Clinical|March 18, 2023
Neuroinflammation and amyloid deposition in the progression of mixed Alzheimer and vascular dementiaChunwei Ying, Peter Kang, Michael M Binkley, et al.The Journal of Biological Chemistry|September 12, 2008
Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannanJordi B Torrelles, Rose Knaup, Avina Kolareth, et al.Journal of Korean Medical Science|March 12, 2014
Clinicopathologic analysis of pituitary adenoma: a single institute experienceHwa Jin Cho, Hanna Kim, Yoon Jin Kwak, et al.Plos One|April 24, 2008
BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family historyGaik Theng Toh, Peter Kang, Sharlene S W Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2014
First-in-human phase I study of Lurbinectedin (PM01183) in patients with advanced solid tumorsMaría Elena Elez, Josep Tabernero, David Geary, et al.Bio-Medical Materials and Engineering|September 26, 2015
Development of biomarker positivity analysis system for cancer diagnosis based on clinical dataJung Min Yun, Sung Jin Hwang, Sung Yong Anh, et al.Plos One|August 27, 2013
Prevalence of PALB2 mutations in breast cancer patients in multi-ethnic Asian population in Malaysia and SingaporeSze Yee Phuah, Sheau Yee Lee, Peter Kang, et al.Breast Cancer Research : BCR|April 18, 2012
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patientsDaphne S C Lee, Sook-Yee Yoon, Lai Meng Looi, et al.Pageof 9